Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective Open-Label Trial of Aripiprazole Monotherapy in the Autism Spectrum Disorders (ASD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00308074
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:17.452801+00:00
Published At
2017-01-02T00:00:00+00:00
Record Updated At
2017-02-15
Results Posted At
2017-01-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Autism", "Asperger\u0027s Disorder", "Pervasive Developmental Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-02-15"
protocolSection.identificationModule.nctId
"NCT00308074"
protocolSection.identificationModule.officialTitle
"A Prospective Open-Label Trial of Aripiprazole Monotherapy in the Autism Spectrum Disorders (ASD)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-01-02"

Study condition terms

  • Autism (protocolSection.conditionsModule.conditions)
  • Asperger's Disorder (protocolSection.conditionsModule.conditions)
  • Pervasive Developmental Disorder (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.